Reports February 2018

 

Hospital admissions, deaths and overall burden of disease attributable to alcohol consumption in Scotland

his report provides an estimate of the number of patient admissions, deaths and overall burden of disease attributable to alcohol in Scotland | ScotPHO, UK

E-cigarettes and heated tobacco products: evidence review

Annual update of Public Health England’s e-cigarette evidence review by leading independent tobacco experts | PHE, UK

PHE launches opioid treatment quality improvement programme

PHE will work with drug treatment providers and service users to develop tools to improve the quality of substitution treatment | PHE, UK

Local tobacco control profiles for England: February 2018 update

An overview of the extent of tobacco use, tobacco related harm, and measures being taken to reduce this harm at a local level in England | PHE, UK

Local Alcohol Profiles for England: February 2018 update

Local Alcohol Profiles for England (LAPE) data update for February 2018 | PHE, UK

Resilient Communities (Full Report) (PDF)

This report's aim was to identify and describe different models/ approaches to developing resilient communities and to assess their effectiveness | PHI, UK

Costs and unintended consequences of drug control policies (PDF)

There is broad consensus that one overall aim of drug policy is to advance the health and welfare of mankind and reduce the individual and public health-related, social and safety problems resulting from the abuse of narcotic drugs and psychotropic substances | Pompidou Group, France

Alcohol: applying All Our Health

Evidence and guidance to help healthcare professionals reduce alcohol-related harm | PHE, UK

Reported road casualties in Great Britain, provisional estimates involving illegal alcohol levels: 2016

Provisional estimates on personal injury drink drive accidents in Great Britain for 2016 | Department of Transport, UK

Police and public health: collaboration

These documents highlight case studies of initiatives between police and health colleagues and identify barriers and enablers to collaboration | PHE, UK

Statistics on Drug Misuse: England, 2018

This statistical report presents a range of information on drug use by adults and children drawn together from a variety of sources. It focuses on England only where possible although some statistics are only readily available at GB or UK level or for England and Wales combined. Some of this is new information whilst some has been published previously | NHS Digital, UK

Programming document 2018–20

The EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new EMCDDA Strategy 2025 | EMCDDA, Portugal

Fentanyl Overdose Reduction Checking Analysis Study (PDF)

The potential of death from even small amounts of fentanyl has changed the landscape of opioid use in the United States. Evidence to date suggests that people who use drugs often do not know whether fentanyl is present in what they are about to consume. A recent study among 242 heroin users across 17 sites in British Columbia, Canada, found that 29% tested positive for fentanyl, 73% of whom did not report knowingly using fentanyl | John Hopkins University, USA

Parental Alcohol Misuse and Children

Parental Alcohol Misuse (PAM) can negatively affect children’s physical and mental health, and other outcomes including educational attainment and behaviour. Effects can be acute when experienced in conjunction with other adverse experiences such as domestic abuse, marital conflict, and deprivation. PAM is a common feature in child protection and care proceedings, and places a considerable burden on social services. Download full report | Parliament.uk, UK

Alcohol and drug prevention, treatment and recovery: why invest?

Local commissioners, providers and healthcare professionals can use the ‘Why invest?’ slides to help make the case for investing in drug and alcohol treatment and interventions | PHE, UK

E-cigarettes and heated tobacco products: evidence review

Annual update of Public Health England’s e-cigarette evidence review by leading independent tobacco experts | PHE, UK

How we drink, What we think: Alcohol in the North East (PDF)

Eight in 10 North Easterners think the UK’s relationship with alcohol is ‘unhealthy’, a major new report has revealed | Balance North East, UK

Safer care for patients with personality disorder (PDF)

Individuals with PD are often frequent users of mental health care. However, management of PD patients is notoriously challenging and influenced by the type of PD, the degree of severity and the presence of comorbid psychiatric disorders | Manchester University, UK

Mapping of specialist primary health care services in England for people who are homeless (PDF)

This report presents the findings of a systematic mapping exercise across England of specialist primary health care services for single people who are homeless. The mapping exercise was part of a larger study that is in progress which is examining the integration, effectiveness and cost-effectiveness of different models of delivering primary health care to people who are homeless | KCL, UK

Stay Well in Wales: The public’s views on public health (PDF)

This report sets out what Wales thinks should be done to improve the health of its residents. [Includes public opinoin relating to information on alcohol, smoking and other drugs] | WALES NHS, UK

Aligning Agendas: Drugs, Sustainable Development, and the Drive for Policy Coherence

Current drug policy too often has a negative impact on communities and runs counter to efforts to ameliorate poverty through sustainable development. However, this is often not captured by the metrics used to measure the impact of drug policy. One way to improve these metrics is to align them with the Sustainable Development Goals (SDGs) | IPU, USA

The Modernization of Treaty Regimes: The Contrasting Cases of International Drug Control and Environmental Regulation (PDF)

Effective international regimes are not static constructs. While there remains definitional variation concerning exactly what constitutes a regime – a situation that exists not only across but also within the increasingly synergistic disciplines of International Relations (IR) and International Law | GDPO, UK

Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Wales: Final report (PDF)

This report was commissioned in June 2017 by the Welsh Government. It uses newly available datasets to update our previously published analyses of the potential impact on the population and population subgroups of different levels of minimum unit pricing (MUP) for alcohol in Wales | Gov.Wales, UK

Family Life in Recovery: Understanding recovery from a family perspective: A survey of life in recovery for families

New research published today (26 February) – the first of its kind – shows how the recovery journey of a dependent drinker can markedly improve the lives of their families, for as long as recovery is sustained | Sheffield Hallam University, Alcohol Research UK, Adfam, UK

Socio-economic inequalities in alcohol consumption and harm: evidence for effective interventions and policy across EU countries (PDF)

This report aims to increase understanding of socio-economic differences in alcohol consumption and harms in the European Union and what can work to reduce these inequalities | European Commission, Belgium

EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl)

In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), through a joint assessment | EMCDDA/Europol, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl)

In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), through a joint assessment | EMCDDA/Europol, Portugal